Home > PS Ratio > PIRAMAL PHARMA

PIRAMAL PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of PIRAMAL PHARMA is 3.58.

Share Price ₹234.9Jan 14,2025
Market Cap ₹31,134.1 Cr
Sales-TTM₹8,703.8 CrTTM-Consolidated Results
Price/Sales3.58xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of PIRAMAL PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of PIRAMAL PHARMA is calculated as :

Current Market Cap [ ₹31,134.1 Cr] as on Jan 14,2025

(/) Sales [ ₹8,703.8 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 3.58x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '3.58 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of PIRAMAL PHARMA !

The chart below summarizes the trend in P/S Ratio of PIRAMAL PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of PIRAMAL PHARMA


PS Ratio Performance Analysis for PIRAMAL PHARMA

- PIRAMAL PHARMA 's latest p/e ratio is 3.58x.

- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2021 averaged 0.81x.

- PIRAMAL PHARMA 's operated at median p/e ratio of 1.15x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2024 at 2.09x.

- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does PIRAMAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
PIRAMAL PHARMA 8,703.83.5831,134.1
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.44424,382.0
CIPLA LTD26,512.04.41116,854.0
DR REDDYS LABORATORIES LTD30,084.93.71111,746.0
ZYDUS LIFESCIENCES LTD21,483.54.69100,704.0
DIVIS LABORATORIES LTD8,614.018.11156,037.0
MANKIND PHARMA LTD11,018.09.72107,078.0
TORRENT PHARMACEUTICALS LTD11,225.09.81110,142.0
LUPIN LTD21,431.34.5397,093.5
AUROBINDO PHARMA LTD30,295.02.2066,638.3
ABBOTT INDIA LTD6,066.19.7358,996.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PIRAMAL PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.20x
Max industry PS 18.11x
Median industry PS 4.69x
Average industry PS 7.18x



You may also like the below Video Courses